• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用具有七个上皮-间质转化相关基因的风险特征来预测肝细胞癌患者的预后。

Risk characteristics with seven epithelial-mesenchymal transition-related genes are used to predict the prognosis of patients with hepatocellular carcinoma.

作者信息

Shi Xianqing, Tu Shuhuan, Zhu Liqun

机构信息

Department of Oncology, Liyang People's Hospital, Liyang, China.

出版信息

J Gastrointest Oncol. 2021 Aug;12(4):1884-1894. doi: 10.21037/jgo-21-394.

DOI:10.21037/jgo-21-394
PMID:34532136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421923/
Abstract

BACKGROUND

Epithelial-mesenchymal transition (EMT)-related genes (ERGs) have been shown to play an important role in cancer invasion, tumor resistance, and tumor metastasis of hepatocellular carcinoma. This study sought to examine the prognostic value of ERGs and other pre-hepatoma genes.

METHODS

Relevant data from The Cancer Genome Atlas (TCGA) were analyzed and synthesized. Specifically, 1,014 ERGs were downloaded and subject to a gene set enrichment analysis; 318 different EAG expressions were found, and the possible molecular mechanism of EAG was predicted by GO analysis and KEGG analysis. To determine the prediction of ERGS, a Cox regression model was used to establish a risk hypothesis. Based on risk patterns, patients were divided into high- or low-risk groups. Kaplan-Meier and receiver operating characteristic (ROC) curves confirmed the predictive value of the model.

RESULTS

Seven prognostically relevant ERGs (i.e., ECT2, EZH2, MYCN, ROR2, SPP1, SQSTM1, and STC2) were identified. Using Cox's regression analysis method, appropriate cases were selected to establish a new risk prediction model. Under the risk model, the overall survival rate of the low-risk group samples was higher than that of the high-risk group samples (P<0.00001).

CONCLUSIONS

In short, we developed a risk model for liver cancer based on ERGs terminology. This model improve the postpartum treatment of patients with liver cancer.

摘要

背景

上皮-间质转化(EMT)相关基因(ERGs)已被证明在肝细胞癌的癌症侵袭、肿瘤耐药性和肿瘤转移中起重要作用。本研究旨在探讨ERGs和其他肝癌前基因的预后价值。

方法

对来自癌症基因组图谱(TCGA)的相关数据进行分析和综合。具体而言,下载了1014个ERGs并进行基因集富集分析;发现了318种不同的EAG表达,并通过GO分析和KEGG分析预测了EAG可能的分子机制。为了确定ERGS的预测情况,使用Cox回归模型建立风险假设。根据风险模式,将患者分为高风险组或低风险组。Kaplan-Meier曲线和受试者工作特征(ROC)曲线证实了该模型的预测价值。

结果

确定了7个与预后相关的ERGs(即ECT2、EZH2、MYCN、ROR2、SPP1、SQSTM1和STC2)。使用Cox回归分析方法,选择合适的病例建立了一个新的风险预测模型。在该风险模型下,低风险组样本的总生存率高于高风险组样本(P<0.00001)。

结论

简而言之,我们基于ERGs术语开发了一种肝癌风险模型。该模型改善了肝癌患者的产后治疗。

相似文献

1
Risk characteristics with seven epithelial-mesenchymal transition-related genes are used to predict the prognosis of patients with hepatocellular carcinoma.利用具有七个上皮-间质转化相关基因的风险特征来预测肝细胞癌患者的预后。
J Gastrointest Oncol. 2021 Aug;12(4):1884-1894. doi: 10.21037/jgo-21-394.
2
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.基于上皮-间质转化相关基因的新型肝细胞癌风险预测模型。
Bioengineered. 2020 Dec;11(1):1034-1046. doi: 10.1080/21655979.2020.1822715.
3
Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.上皮间质转化相关的肝细胞癌预后模型的建立和验证。
Aging (Albany NY). 2021 Apr 30;13(10):13822-13845. doi: 10.18632/aging.202976.
4
An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.一种预测肝细胞癌患者预后的上皮-间质转化相关5基因特征
Cancer Cell Int. 2021 Mar 12;21(1):166. doi: 10.1186/s12935-021-01864-5.
5
Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.一种用于肝细胞癌的稳健的上皮-间质转化(EMT)相关预后标志物的开发与验证
Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101587. doi: 10.1016/j.clinre.2020.101587. Epub 2021 Mar 1.
6
Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.构建肺腺癌的预后免疫相关长链非编码RNA风险模型
Front Cell Dev Biol. 2021 Mar 18;9:648806. doi: 10.3389/fcell.2021.648806. eCollection 2021.
7
Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.基于上皮-间质转化相关基因建立子宫内膜癌患者的预后标志物。
Front Immunol. 2022 Jan 14;12:805883. doi: 10.3389/fimmu.2021.805883. eCollection 2021.
8
Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.鉴定和验证胃癌患者中 EMT 相关的个体化预后风险评分公式。
Biomed Res Int. 2020 Mar 20;2020:7082408. doi: 10.1155/2020/7082408. eCollection 2020.
9
Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.结直肠癌患者上皮-间质转化的基因组学与预后分析。
BMC Cancer. 2020 Nov 23;20(1):1135. doi: 10.1186/s12885-020-07615-5.
10
A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.一种基于凋亡相关基因的肝细胞癌预后模型。
World J Surg Oncol. 2021 Mar 12;19(1):70. doi: 10.1186/s12957-021-02175-9.

本文引用的文献

1
Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.一种用于肝细胞癌的稳健的上皮-间质转化(EMT)相关预后标志物的开发与验证
Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101587. doi: 10.1016/j.clinre.2020.101587. Epub 2021 Mar 1.
2
A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.基于上皮-间质转化相关基因的新型肝细胞癌风险预测模型。
Bioengineered. 2020 Dec;11(1):1034-1046. doi: 10.1080/21655979.2020.1822715.
3
A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma.一种用于预测肝细胞癌预后的强大的十二基因特征。
Cancer Cell Int. 2020 Jun 3;20:207. doi: 10.1186/s12935-020-01294-9. eCollection 2020.
4
Accelerates Hepatocellular Carcinoma Progression by Driving the Epithelial-to-Mesenchymal Transition.通过驱动上皮-间质转化促进肝细胞癌进展
Onco Targets Ther. 2020 May 8;13:3931-3942. doi: 10.2147/OTT.S237804. eCollection 2020.
5
Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression.锌指蛋白 703 通过反式激活 Claudin4 表达诱导肝癌中的 EMT 和索拉非尼耐药。
Cell Death Dis. 2020 Apr 8;11(4):225. doi: 10.1038/s41419-020-2422-3.
6
Development and validation of a survival model for lung adenocarcinoma based on autophagy-associated genes.基于自噬相关基因的肺腺癌生存模型的建立与验证
J Transl Med. 2020 Apr 1;18(1):149. doi: 10.1186/s12967-020-02321-z.
7
HSP4 triggers epithelial-mesenchymal transition and promotes motility capacities of hepatocellular carcinoma cells via activating AKT.热休克蛋白4(HSP4)通过激活蛋白激酶B(AKT)触发上皮-间质转化并促进肝癌细胞的运动能力。
Liver Int. 2020 May;40(5):1211-1223. doi: 10.1111/liv.14410. Epub 2020 Mar 8.
8
The critical role of glucose deprivation in epithelial-mesenchymal transition in hepatocellular carcinoma under hypoxia.葡萄糖剥夺在低氧环境下肝癌上皮间质转化中的关键作用。
Sci Rep. 2020 Jan 30;10(1):1538. doi: 10.1038/s41598-020-58124-1.
9
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.基质金属蛋白酶在肝癌上皮-间质转化中的作用。
Anal Cell Pathol (Amst). 2019 Nov 26;2019:9423907. doi: 10.1155/2019/9423907. eCollection 2019.
10
Association between the expression of secreted phosphoprotein - related genes and prognosis of human cancer.分泌磷蛋白相关基因的表达与人类癌症预后的关系。
BMC Cancer. 2019 Dec 18;19(1):1230. doi: 10.1186/s12885-019-6441-3.